Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
Abroad (travel likely)RecruitingPHASE2
Conditions
NAFLD
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Virginia Commonwealth University, Richmond, Virginia, United States
Study leads
Mohammad S Siddiqui, MD
Principal Investigator
Virginia Commonwealth University